Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 50

Sort by

Sort Order Select

Journal Articles

Proteomics Landscape and Machine Learning Predictor of Response to Splenectomy in Immune Thrombocytopenia

Chen Jia, Ting Sun, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 2566.

https://doi.org/10.1182/blood-2023-173108

Published: 2023

Journal Articles

CM313, a Novel Anti-CD38 Antibody, As a Potential Treatment for Primary Immune Thrombocytopenia: A Phase II Trial

Yunfei Chen, Xu Yanmei, Xuan Cao, Feng Xue, Ting Sun, Wei Liu, Mankai Ju, Rongfeng Fu, Xiaofan Liu, Xinyue Dai, Huiyuan Li, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 1206.

https://doi.org/10.1182/blood-2023-188664

Published: 2023

Journal Articles

Sex-Specific Impact on Disease Outcome and Mutational Landscape in Essential Thrombocythemia

Chen Jia, Huan Dong, Ting Sun, Rongfeng Fu, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 1824.

https://doi.org/10.1182/blood-2023-173112

Published: 2023

Journal Articles

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Blood (2023) 142 (Supplement 1): 2624.

https://doi.org/10.1182/blood-2023-174698

Published: 2023

Journal Articles

Efficacy and Safety of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Immune Thrombocytopenia: A Prospective, Single Centre, Single Arm, Phase I Trial

Blood (2023) 142 (Supplement 1): 687.

https://doi.org/10.1182/blood-2023-174591

Published: 2023

Journal Articles

The Relationship between Telomere Length and Epigenetic Aging with Hematologic Diseases Risk: A Multivariable Mendelian Randomisation Study

Yang Li, Chen Jia, Ting Sun, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 1316.

https://doi.org/10.1182/blood-2023-173594

Published: 2023

Journal Articles

Pharmacokinetics, Safety and Preliminary Efficacy of Multiple Doses of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW117) in Previously Treated Adult and Adolescent Subjects with Severe Hemophilia a: Results from an Open-Label, Multicenter, Phase 2 Study

Feng Xue, Weizhi Chen, Shuxia Guo, Haiying Hua, Yu Cao, Xianqi Feng, Renchi Yang

Blood (2023) 142 (Supplement 1): 2615.

https://doi.org/10.1182/blood-2023-180649

Published: 2023

Journal Articles

Factor XI Deficiency in Chinese Patients: Results from a Nationwide Multicenter Retrospective Study

Xiyan Wang, Feng Xue, Wei Liu, Linging Chen, Lei Zhang, Renchi Yang

Blood (2023) 142 (Supplement 1): 5477.

https://doi.org/10.1182/blood-2023-184688

Published: 2023

Journal Articles

Global Burden and Disparities in Hematologic Malignancies: A Comparative Analysis from 1990 to 2019

Yang Li, Chen Jia, Ting Sun, Lei Zhang, Renchi Yang

Blood (2023) 142 (Supplement 1): 7280.

https://doi.org/10.1182/blood-2023-173597

Published: 2023

Journal Articles

Comparative Analysis of Bone Marrow Microbiome and Proteome Differences between Essential Thrombocythaemia and Prefibrotic Primary Myelofibrosis

Anqi Zhang, Ting Sun, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 4577.

https://doi.org/10.1182/blood-2023-189072

Published: 2023

Journal Articles

Clinical Study of Lymphocyte Subsets in Patients with BCR/ABL Negative Myeloproliferative Neoplasms

Fei Li, Ziwei Chen, Shixuan Wang, Renchi Yang

Blood (2023) 142 (Supplement 1): 6420.

https://doi.org/10.1182/blood-2023-180087

Published: 2023

Journal Articles

Acquired Hemophilia a: A Single-Center Study of 165 Patients

Dandan Yu, Feng Xue, Xiaofan Liu, Yunfei Chen, Rongfeng Fu, Ting Sun, Xinyue Dai, Mankai Ju, Huan Dong, Renchi Yang, Wei Liu, Lei Zhang

Blood (2023) 142 (Supplement 1): 2623.

https://doi.org/10.1182/blood-2023-173407

Published: 2023

Journal Articles

A Single-Center Study of Patients with Isolated Acquired Clotting Factor Deficiency: Clinical Features, Treatments, and Prognosis

Dandan Yu, Feng Xue, Xiaofan Liu, Yunfei Chen, Rongfeng Fu, Ting Sun, Xinyue Dai, Mankai Ju, Huan Dong, Renchi Yang, Wei Liu, Lei Zhang

Blood (2023) 142 (Supplement 1): 3995.

https://doi.org/10.1182/blood-2023-173431

Published: 2023

Journal Articles

An Innovative Dynamic Nomogram for Stratifying Survival Prognosis in Essential Thrombocythemia Patients with a History of Thrombosis

Chen Jia, Ting Sun, Rongfeng Fu, Huan Dong, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 6390.

https://doi.org/10.1182/blood-2023-173111

Published: 2023

Journal Articles

Association between Inflammatory Factors and Myeloproliferative Neoplasm: A Bidirectional Mendelian Randomization Study

Yang Li, Chen Jia, Ting Sun, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 6413.

https://doi.org/10.1182/blood-2023-173596

Published: 2023

Journal Articles

Single-Dose Rituximab Plus Glucocorticoid Versus Cyclophosphamide Plus Glucocorticoid in Patients with Newly Diagnosed Acquired Hemophilia a: A Multicenter, Open-Label, Randomized Clinical Trial

Wei Liu, Rongfu Zhou, Panjing Wang, Hu Zhou, Jie Bai, Xianghua Wang, Yueshen Ma, Zhen Song, Yunfei Chen, Xiaofan Liu, Rongfeng Fu, Ting Sun, Mankai Ju, Xinyue Dai, Huan Dong, Feng Xue, Renchi Yang, Lei Zhang

Blood (2023) 142 (Supplement 1): 2628.

https://doi.org/10.1182/blood-2023-174587

Published: 2023

Journal Articles

Short-Term Efficacy of Combination Therapy with Recombinant Human Thrombopoietin (rh-TPO) and Thrombopoietin Receptor Agonists (TPO-Ra) in Patients with Severe Immune Thrombocytopenia

Renxia Li, Wen Yang, Yaxian Tan, Renchi Yang, ZePing Zhou

Blood (2023) 142 (Supplement 1): 5445.

https://doi.org/10.1182/blood-2023-188288

Published: 2023

Journal Articles

A Single-Center Study of Patients with Isolated Acquired Clotting Factors Deficiency: Clinical Features, Treatments and Prognosis

Yu Dandan, Wei Liu, Yunfei Chen, Rongfeng Fu, Liu Xiaofan, Ting Sun, Mankai Ju, Xinyue Dai, Feng Xue, Renchi Yang, Lei Zhang

Blood (2022) 140 (Supplement 1): 11325.

https://doi.org/10.1182/blood-2022-156991

Published: 2022

Journal Articles

Multi-Omics Analysis of Human Mesenchymal Stem Cell Guides Perinatal MSC Based Cellular Therapy for Splenectomy-Nonresponsive Refractory Immune Thrombocytopenia: A Phase I Clinical Trial

Blood (2022) 140 (Supplement 1): 1974–1976.

https://doi.org/10.1182/blood-2022-156764

Published: 2022

Journal Articles

Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial

Blood (2022) 140 (Supplement 1): 5543–5545.

https://doi.org/10.1182/blood-2022-162945

Published: 2022

NARROW

Proteomics Landscape and Machine Learning Predictor of Response to Splenectomy in Immune Thrombocytopenia

CM313, a Novel Anti-CD38 Antibody, As a Potential Treatment for Primary Immune Thrombocytopenia: A Phase II Trial

Sex-Specific Impact on Disease Outcome and Mutational Landscape in Essential Thrombocythemia

Emicizumab Prophylaxis for the Treatment of Chinese Hemophilia A Patients in the Real World: A Multi-Center Retrospective Analysis

Efficacy and Safety of Human Umbilical Cord-Derived Mesenchymal Stem Cells in the Treatment of Immune Thrombocytopenia: A Prospective, Single Centre, Single Arm, Phase I Trial

The Relationship between Telomere Length and Epigenetic Aging with Hematologic Diseases Risk: A Multivariable Mendelian Randomisation Study

Pharmacokinetics, Safety and Preliminary Efficacy of Multiple Doses of Pegylated Recombinant Human Coagulation Factor VIII-Fc Fusion Protein (FRSW117) in Previously Treated Adult and Adolescent Subjects with Severe Hemophilia a: Results from an Open-Label, Multicenter, Phase 2 Study

Factor XI Deficiency in Chinese Patients: Results from a Nationwide Multicenter Retrospective Study

Global Burden and Disparities in Hematologic Malignancies: A Comparative Analysis from 1990 to 2019

Comparative Analysis of Bone Marrow Microbiome and Proteome Differences between Essential Thrombocythaemia and Prefibrotic Primary Myelofibrosis

Clinical Study of Lymphocyte Subsets in Patients with BCR/ABL Negative Myeloproliferative Neoplasms

Acquired Hemophilia a: A Single-Center Study of 165 Patients

A Single-Center Study of Patients with Isolated Acquired Clotting Factor Deficiency: Clinical Features, Treatments, and Prognosis

An Innovative Dynamic Nomogram for Stratifying Survival Prognosis in Essential Thrombocythemia Patients with a History of Thrombosis

Association between Inflammatory Factors and Myeloproliferative Neoplasm: A Bidirectional Mendelian Randomization Study

Single-Dose Rituximab Plus Glucocorticoid Versus Cyclophosphamide Plus Glucocorticoid in Patients with Newly Diagnosed Acquired Hemophilia a: A Multicenter, Open-Label, Randomized Clinical Trial

Short-Term Efficacy of Combination Therapy with Recombinant Human Thrombopoietin (rh-TPO) and Thrombopoietin Receptor Agonists (TPO-Ra) in Patients with Severe Immune Thrombocytopenia

A Single-Center Study of Patients with Isolated Acquired Clotting Factors Deficiency: Clinical Features, Treatments and Prognosis

Multi-Omics Analysis of Human Mesenchymal Stem Cell Guides Perinatal MSC Based Cellular Therapy for Splenectomy-Nonresponsive Refractory Immune Thrombocytopenia: A Phase I Clinical Trial

Switching from Eltrombopag to Hetrombopag in Patients with Primary Immune Thrombocytopenia (ITP): Post-Hoc Analysis of a Multicenter, Randomized Phase III Trial

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only